Unknown

Dataset Information

0

Prognostic significance of high GFI1 expression in AML of normal karyotype and its association with a FLT3-ITD signature.


ABSTRACT: Growth Factor Independence 1 (GFI1) is a transcriptional repressor that plays a critical role during both myeloid and lymphoid haematopoietic lineage commitment. Several studies have demonstrated the involvement of GFI1 in haematological malignancies and have suggested that low expression of GFI1 is a negative indicator of disease progression for both myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML). In this study, we have stratified AML patients into those defined as having a normal karyotype (CN-AML). Unlike the overall pattern in AML, those patients with CN-AML have a poorer survival rate when GFI1 expression is high. In this group, high GFI1 expression is paralleled by higher FLT3 expression, and, even when the FLT3 gene is not mutated, exhibit a FLT3-ITD signature of gene expression. Knock-down of GFI1 expression in the human AML Fujioka cell line led to a decrease in the level of FLT3 RNA and protein and to the down regulation of FLT3-ITD signature genes, thus linking two major prognostic indicators for AML.

SUBMITTER: Volpe G 

PROVIDER: S-EPMC5593973 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prognostic significance of high GFI1 expression in AML of normal karyotype and its association with a FLT3-ITD signature.

Volpe Giacomo G   Walton David S DS   Grainger David E DE   Ward Carl C   Cauchy Pierre P   Blakemore Daniel D   Coleman Daniel J L DJL   Cockerill Peter N PN   Garcia Paloma P   Frampton Jon J  

Scientific reports 20170911 1


Growth Factor Independence 1 (GFI1) is a transcriptional repressor that plays a critical role during both myeloid and lymphoid haematopoietic lineage commitment. Several studies have demonstrated the involvement of GFI1 in haematological malignancies and have suggested that low expression of GFI1 is a negative indicator of disease progression for both myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML). In this study, we have stratified AML patients into those defined as having a n  ...[more]

Similar Datasets

2008-08-22 | GSE12417 | GEO
2008-02-28 | GSE8043 | GEO
2008-02-27 | E-GEOD-8043 | biostudies-arrayexpress
| S-EPMC5045383 | biostudies-literature
| S-EPMC6853146 | biostudies-literature
| S-EPMC5519068 | biostudies-other
| S-EPMC8075860 | biostudies-literature
| S-EPMC7796342 | biostudies-literature
| S-EPMC2384125 | biostudies-literature
2005-10-27 | GSE3505 | GEO